Toll-like receptor 2 mediates inhibition of HCO3- absorption by bacterial lipoprotein in medullary thick ascending limb

American Journal of Physiology - Renal Physiology

Volumn 299, Issue 3, 2010, Pages

  Good, David W ^a   George, Thampi ^a   Watts III, Bruns A ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Acid base transport; Gram positive bacteria; Kidney; LPS; Sepsis

Indexed keywords

BICARBONATE; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; PAM(3)CSK(4) PEPTIDE; PEPTIDOGLYCAN; PROTEIN KINASE C; TEICHOIC ACID; TLR2 PROTEIN, MOUSE; TLR2 PROTEIN, RAT; TLR4 PROTEIN, MOUSE; TLR4 PROTEIN, RAT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

AGONISTS; ANIMAL; ANIMAL MODEL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL MEMBRANE; DRUG EFFECTS; HENLE LOOP; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BICARBONATES; BIOLOGICAL TRANSPORT; CELL MEMBRANE; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; LOOP OF HENLE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; PEPTIDOGLYCAN; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 77956465548     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00108.2010     Document Type: Article

References (88)

1. Ahn KO, Lim SW, Yang HJ, Ghee JY, Kim JY, Kim SH, Kim J, Yang CW. Influence of angiotensin II on expression of Toll-like receptor 2 and maturation of dendritic cells in chronic cyclosporine nephropathy. Transplantation 83: 938-947, 2007.
2. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 124: 783-801, 2006.
3. Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A, Palazzo M, Moreno R, Boulme R, Lepage E, Le Gall JR. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28: 108-121, 2002.
4. Alexopoulou L, Thomas V, Schnare M, Lobet Y, Anguita J, Schoen RT, Medzhitov R, Fikrig E, Flavell RA. Hyporesponsiveness to vaccination with borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat Med 8: 878-884, 2002.
5. Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, Klimpel GR, Godowski P, Zychlinsky A. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor 2. Science 285: 736-739, 1999. (Pubitemid 129505077)
6. Anders HJ, Banas B, Schlondorff D. Signaling danger: Toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol 15: 854-867, 2004.
7. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P, Bellissant E. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288: 862-871, 2002.
8. Arbibe L, Mira JP, Teusch N, Kline L, Guha M, Mackman N, Godowski PJ, Ulevitch RJ, Knaus UG. Toll-like receptor 2-mediated NF-B activation requires a Rac1-dependent pathway. Nat Immunol 1: 533-540, 2000.
9. Aristimuno PC, Good DW. PKC isoforms in rat medullary thick ascending limb: selective activation of the isoform by PGE2. Am J Physiol Renal Physiol 272: F624-F631, 1997. (Pubitemid 127750939)
10. Austgen TR, Chen MK, Moore W, Souba WW. Endotoxin and renal glutamine metabolism. Arch Surg 126: 23-27, 1991.
11. Banerjee A, Gugasyan R, McMahon M, Gerondakis S. Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells. Proc Natl Acad Sci USA 103: 3274-3279, 2006.
12. Baumgart K, Radermacher P, Calzia E, Hauser B. Pathophysiology of tissue acidosis in septic shock: blocked microcirculation or impaired cellular respiration. Crit Care Med 36: 640-642, 2008.
13. Beg AA. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol 23: 509-512, 2002.
14. Blanco J, Muriel-Bombin A, Sagredo V, Taboada F, Gandia F, Tamayo L, Collado J, Garcia-Labattut A, Carriedo D, Valledor M, De Frutos M, Lopez MJ, Caballero A, Guerra J, Alvarez B, Mayo A, Villar J. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 12: R158-R171, 2008.
15. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST, Brennan PJ, Bloom BR, Godowski PJ, Modlin RL. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285: 732-736, 1999.
16. Brown HJ, Lock HR, Sacks SH, Robson MG. TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis. J Immunol 177: 1925-1931, 2006.
17. Buwitt-Beckmann U, Heine H, Wiesmuller KH, Jung G, Brock R, Akira S, Ulmer AJ. TLR1- and TLR6-independent recognition of bacterial lipopeptides. J Biol Chem 281: 9049-9057, 2006.
18. Cario E, Guido G, Podolsky DK. Toll-like receptor 2 enhances ZO-1- associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127: 224-238, 2004. (Pubitemid 38962290)
19. Chowdhury P, Sacks SH, Sheerin NS. Minireview: functions of the renal tract epithelium in coordinating the innate immune response to infection. Kidney Int 66: 1334-1344, 2004.
20. Chowdhury P, Sacks SH, Sheerin NS. Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products. Clin Exp Immunol 145: 346-356, 2006.
21. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev 19: 403-434, 2006.
22. Cohen J. The immunopathogenesis of sepsis. Nature 420: 885-891, 2002.
23. DeGroot K, Kuklik K, Brocker V, Schwarz A, Gwinner W, Kreipe H, Haller H, Fliser D, Mengel M. Toll-like receptor 2 and renal allograft function. Am J Nephrol 28: 583-588, 2008.
24. Dollins M, Kraus MA, Molitoris BA. Intensive care nephropathy. Sepsis. In: Brenner and Rector's The Kidney, vol. 2, edited by Brenner BM. Philadelphia, PA: Saunders, 2008, p. 2045-2050.
25. El-Achkar TM, Dagher PC. Renal Toll-like receptors: recent advances and implications for disease. Nat Clin Pract Nephrol 2: 568-581, 2006. (Pubitemid 44465679)
26. El-Achkar TM, Hosein M, Dagher PC. Pathways of renal injury in systemic gram-negative sepsis. Eur J Clin Invest 38: 39-44, 2008.
27. Faisal A, Saurin A, Gregory B, Foxwell B, Parker PJ. The scaffold MyD88 acts to couple protein kinase Cε to Toll-like receptors. J Biol Chem 283: 18591-18600, 2008.
28. Foxman B, Barlow R, D'Arcy H, Gillespi B, Sobel JD. Urinary tract infection. Self-reported incidence and associated costs. Ann Epidemiol 10: 509-515, 2000.
29. Geerlings SE, Brouwer EC, Gaastra W, Verhoef J, Hoepelman AI. Effect of glucose and pH on uropathogenic and nonuropathogenic Escherichia coli: studies with urine from diabetic and non-diabetic individuals. J Med Microbiol 48: 535-539, 1999.
30. Gomez J, Garcia-Vazquez E, Banos R, Canteras M, Ruiz J, Banos V, Herrero JA, Valdes M. Predictors of mortality in patients with methicillin- resistant Staphylococcus aureus bacteremia: the role of empiric antibiotic therapy. Eur J Clin Microbiol Infect Dis 26: 239-245, 2007.
31. Good DW. Inhibition of bicarbonate absorption by peptide hormones and cyclic adenosine monophosphate in rat medullary thick ascending limb. J Clin Invest 85: 1006-1013, 1990.
32. - absorption in rat MTAL by activation of protein kinase C. Am J Physiol Renal Fluid Electrolyte Physiol 270: F978-F985, 1996.
33. - absorption through parallel phosphatidylinositol 3-kinase-mTOR and ERK pathways in thick ascending limb. J Biol Chem 283: 26602-26611, 2008.
34. Good DW, George T, Watts III BA. Lipopolysaccharide directly alters renal tubule transport through distinct TLR4-dependent pathways in basolateral and apical membranes. Am J Physiol Renal Physiol 297: F866-F874, 2009.
35. + exchanger null mutant mice. Am J Physiol Renal Physiol 287: F1244-F1249, 2004.
36. Grinevich V, Knepper M, Verbalis J, Reyes I, Aguilera G. Acute endotoxemia in rats induces downregulation of V2 vasopressin receptors and aquaporin-2 content in the kidney medulla. Kidney Int 65: 54-62, 2004. (Pubitemid 38037491)
37. Hagberg L, Hull R, Hull S, McGhee JR, Michalek SM, Eden CS. Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun 46: 839-844, 1984.
38. Herbert JM, Augereau JM, Gleye J, Maffrand JP. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172: 993-999, 1990.
39. Jones BW, Heldwein KA, Means TK, Fenton MJ. Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages. Ann Rheum Dis 60: iii6 -iii12, 2001.
40. Kawai T, Akira S. TLR signaling. Cell Death Differ 13: 816-825, 2006.
41. Kaye D. Antibacterial activity of human urine. J Clin Invest 47: 2374-2390, 1968.
42. Kim BS, Lim SW, Li C, Kim JS, Sun BK, Ahn KO, Han SW, Kim J, Yang CW. Ischemia-reperfusion injury activates innate immunity in rat kidneys. Transplantation 79: 1370-1377, 2005.
43. Klenzak J, Himmelfarb J. Sepsis and the kidney. Crit Care Clin 21: 211-222, 2005.
44. Kraut JA, Kurtz I. Use of base in the treatment of severe acidemic states. Am J Kidney Dis 38: 703-727, 2001. (Pubitemid 33666516)
45. Lee SW, Hong YS, Park DW, Chio SH, Moon SW, Park JS, Kim JY, Baek KJ. Acidosis not hyperlactatemia as a predictor of in hospital mortality in septic emergency patients. Emerg Med J 25: 659-665, 2008.
46. Leemans JC, Butter LM, Pulskens PC, Teske GJD, Claessen N, van der Poll T, Florquin S. The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS ONE 4: e5704, 2009.
47. Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJD, Kirschning CJ, Akira S, van der Poll T, Weening JJ, Florquin S. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 115: 2894-2903, 2005.
48. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. JAMA 275: 1489-1494, 1996.
49. Lim SW, Li C, Ahn KO, Moon IS, Ahn C, Lee JR, Yang CW. Cyclosporine-induced renal injury induces Toll-like receptor and maturation of dendritic cells. Transplantation 80: 691-699, 2005.
50. Marik PE, Varon J. Sepsis: state of the art. Dis Mon 47: 465-532, 2001.
51. Miyake K. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin Immunol 19: 3-10, 2007.
52. Mkaddem SB, Werts C, Goujon JM, Bens M, Pedruzzi E, Ogier-Denis E, Vandewalle A. Heat shock protein gp96 interacts with protein phosphatase 5 and controls Toll-like receptor 2-mediated activation of extracellular signal-regulated kinase 1/2 in posthypoxic kidney cells. J Biol Chem 284: 12541-12549, 2009.
53. Morath S, Geyer A, Hartung T. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J Exp Med 193: 393-397, 2001.
54. Morr M, Takeuchi O, Akira S, Simon MM, Muhlradt PF. Differential recognition of structural details of bacterial lipopeptides by toll-like receptors. Eur J Immunol 32: 3337-3347, 2002.
55. Naresh G, Mansharamani MD, Koziel H. Chronic lung sepsis: lung abscess, bronchiectasis, and empyema. Curr Opin Pulm Med 9: 181-185, 2003.
56. Oppert M, Engel C, Brunkhorst FM, Bogatsch H, Reinhart K, Frei U, Eckardt KU, Loeffler M, John S. Acute renal failure in patients with severe sepsis and septic shock-a significant independent risk factor for mortality: results from the German Prevalence Study. Nephrol Dial Transplant 23: 904-909, 2008.
57. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, Aderem A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci USA 97: 13766-13771, 2000.
58. Patole PS, Schubert S, Hildinger K, Khandoga S, Khandoga A, Segerer S, Henger A, Kretzler M, Werner M, Krombach F, Schlondorff D, Anders HJ. Toll-like receptor-4: renal cells and bone marrow cells signal for neutrophil recruitment during pyelonephritis. Kidney Int 68: 2582-2587, 2005.
59. Pittet JF, Wiener-Kronish JP, McElroy MC, Folkesson HG, Matthay MA. Stimulation of lung epithelial liquid clearance by endogenous release of catecholamines in septic shock in anesthetized rats. J Clin Invest 94: 663-671, 1994.
60. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr Mice: mutations in Tlr4 gene. Science 282: 2085-2088, 1998.
61. Rahman N, Meng M, Stoller M. Infections and urinary stone disease. Curr Pharm Des 9: 975-981, 2003.
62. Russell JA, Singer J, Bernard GR, Wheeler A, Fulkerson W, Hudson L, Schein R, Summer W, Wright P, Walley KR. Changing pattern of organ dysfunction in early human sepsis is related to mortality. Crit Care Med 28: 3405-3411, 2000.
63. Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, Parsonnet J, Panzer R, Orav EJ, Snydman DR, Black E, Schwartz JS, Moore R, Johnson BL Jr, Platt R. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 278: 234-240, 1997.
64. Scheibner KA, Litz MA, Boodoo S, Fenton MJ, Powell JD, Horton MR. Hyaluronin fragments act as an endogenous danger signal by engaging TLR2. J Immunol 177: 1272-1281, 2006. (Pubitemid 44036633)
65. Schmidt C, Hocherl K, Bucher M. Regulation of renal glucose transporters during severe inflammation. Am J Physiol Renal Physiol 292: F804-F811, 2007. (Pubitemid 46220549)
66. Schmidt C, Hocherl K, Schweda F, Kurtz A, Bucher M. Regulation of renal sodium transporters during severe inflammation. J Am Soc Nephrol 18: 1072-1083, 2007. (Pubitemid 46536893)
67. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 351: 159-169, 2004.
68. Schwan W, Lee J, Lenard F, Mathews B, Beck M. Osmolarity and pH growth conditions regulate fim gene transcription and type 1 pilus expression in uropathogenic Escherichia coli. Infect Immun 70: 1391-1402, 2002.
69. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J Biol Chem 274: 17406-17409, 1999. (Pubitemid 129519082)
70. Shigeoka AA, Holscher TD, King AJ, Hall FW, Kiosses WK, Tobias PS, Mackman N, McKay DB. TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J Immunol 178: 6252-6258, 2007.
71. Shirali AC, Goldstein DR. Tracking the Toll of kidney disease. J Am Soc Nephrol 19: 1444-1450, 2008.
72. Strassheim D, Asehnoune K, Park JS, Kim JY, Qianbin H, Richter D, Kuhn K, Mitra S, Abraham E. Phosphoinositide 3-kinase and Akt occupy central roles in inflammatory responses of Toll-like receptor 2-stimulated neutrophils. J Immunol 172: 5727-5733, 2004.
73. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11: 443-451, 1999.
74. Takeuchi O, Kawai T, Muhlradt PF, Morr M, Radolf JD, Zychlinsky A, Takeda K, Akira S. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 13: 933-940, 2001.
75. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL, Akira S. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 169: 10-14, 2002. (Pubitemid 34686113)
76. Tan SL, Parker PJ. Emerging and diverse roles of protein kinase C in immune cell signaling. Biochem J 376: 545-552, 2003.
77. Teusch N, Lombardo E, Eddleston J, Knaus UG. The low molecular weight GTPase RhoA and atypical protein kinase Cζ are required for TLR2-mediated gene transcription. J Immunol 173: 507-514, 2004. (Pubitemid 38797378)
78. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D, Kirilovsky J. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266: 15771-15781, 1991.
79. Tsuboi N, Yoshikai Y, Matsuo S, Kikuchi T, Iwami KI, Nagai Y, Takeuchi O, Akira S, Matsuguchi T. Roles of Toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 169: 2026-2033, 2002. (Pubitemid 34857667)
80. Wang W, Li C, Summer SN, Falk S, Wang W, Ljubanovic D, Schrier RJ. Role of AQP1 in endotoxemia-induced acute kidney injury. Am J Physiol Renal Physiol 294: F1473-F1480, 2008.
81. - absorption through actin cytoskeleton remodeling in renal thick ascending limb. J Biol Chem 280: 11439-11447, 2005.
82. - absorption via a nongenomic, ERK-dependent pathway in medullary thick ascending limb. Am J Physiol Renal Physiol 291: F1005-F1013, 2006.
83. - absorption by nerve growth factor in MTAL. Am J Physiol Renal Physiol 282: F1056-F1063, 2002.
84. Wolfs TGAM, Buurman WA, van Schadewijk A, de Vries B, Daemen MARC, Hiemstra PS, van't Veer C. In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-γ and TNF-α mediated upregulation during inflammation. J Immunol 168: 1286-1293, 2002.
85. Wooten RM, Ma Y, Yoder RA, Brown JP, Weiss JH, Zachary JF, Kirshning CJ, Weiss JJ. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borellia burgdorferi. J Immunol 168: 348-355, 2002. (Pubitemid 34014136)
86. Yang CS, Lee JS, Song CH, Hur GM, Lee SJ, Tanaka S, Akira S, Paik TH, Jo EK. Protein kinase C zeta plays an essential role for Mycobacterium tuberculosis-induced extracellular signal-regulated kinase 1/2 activation in monocytes/macrophages via Toll-like receptor 2. Cell Microbiol 9: 382-396, 2007. (Pubitemid 46092167)
87. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D. Cutting edge: recognition of gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 163: 1-5, 1999. (Pubitemid 29295815)
88. Zhanel GG, Karlowsky JA, Davidson RJ, Hoban DJ. Influence of human urine on the in vitro activity and postantibiotic effect of ciprofloxacin against Escherichia coli. Chemotherapy 37: 218-223, 1991.